Early Data Suggest Tradipitant May Accelerate Recovery in COVID-19 Pneumonia
The ODYSSEY study is evaluating the efficacy and safety of tradipitant in adults with neurogenic inflammation of the lung secondary to COVID-19 infection.
COVID19
Neck Gaiters ‘Worse Than Nothing’ in Preventing COVID-19 Spread
Researchers find using neck gaiter could actually spread the virus further than using no face covering at all.
Convalescent Plasma Efficacious for Severe COVID-19
Significant reduction seen in mortality, specifically among patients transfused with plasma within 72 hours.
MPR Weekly Dose Podcast Episode 47
This week we have remdesivir news; A new opioid and spinal muscular atrophy treatments are approved; A sublingual epinephrine treatment; And the latest on Biogen’s investigational Alzheimer disease treatment. Also, we have a brief summary of the other drugs in the pipeline from the past week.
Russia Approves COVID-19 Vaccine Before Trials Completed
President Vladimir Putin claims the vaccine ‘works effectively enough’.
FDA Head Says Any Approved COVID-19 Vaccine Will Be Safe
Assurance was given during a video briefing with the American Medical Association.
New Drug Application for Remdesivir Submitted
Remdesivir is an investigational nucleotide analogue with broad-spectrum antiviral activity.
Report: 97,000 US Children Infected With COVID-19 in Late July
States in the South and West accounted for more than 7 of 10 infections.
MPR Weekly Dose Podcast Episode 46
This week there’s more COVID vaccine developments; A first-of-its-kind trial assessing a drug for preventing COVID in long term care facilities; A cannabidiol treatment gains another indication; Depression treatment gains indication for major depressive disorders with acute suicidal ideation or behavior; And the FDA requests more information for their review of the peanut allergy treatment, Viaskin.
NIH: Remdesivir Plus Interferon Beta-1a Being Evaluated for COVID-19
The placebo-controlled ACTT 3 trial will evaluate the efficacy and safety of remdesivir in combination with interferon beta-1a in more than 1000 hospitalized COVID-19 patients.
